Impaired Cardioprotection by HDL in CAD and Diabetes in Ischemia/Reperfusion Injury: role of S1P and SR-BI

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Associate Professor Amin Polzin

Heinrich Heine University, Duesseldorf (Germany)

4 More presentations in this session

Presentation thumbnail

FYCO1 ameliorates adverse cardiac remodeling in response to myocardial ischemia by enhancing autophagic flux

Miss F. Senger (Heidelberg, DE)

Abstract Slides Video

Presentation thumbnail

Systemic GDF11 replenishment ignites myocardial injury through diminishing anti-apoptotic activity of cardiac progenitor cells

Doctor S. Kraler (Bern, CH)

Abstract Slides Video

Presentation thumbnail

Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Doctor P. Nikolaou (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection via the purinergic P2Y13 receptor and nitric oxide signalling

Doctor T. JIAO (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Myocardial ischaemia and protective mechanisms

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

High levels of high-density lipoprotein cholesterol (HDL-C) and major adverse cardiovascular events and 10-year all-cause mortality:results from Women's Ischemia Syndrome Evaluation (WISE) study

Congress Presentation

The high HDL controversy continues: the prognosis for women with a high HDL profile is seriously unfavourable

Congress Presentation

Dysfunctional high-density lipoproteins in breast cancer patients and tumor-bearing mice treated with chemotherapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources